Lenalidomide,Idecabtagene vicleucel
bms,2seventy bio
['multiplemyeloma', 'bristol', '$bmy']
#bristolmyerssquibb announces first disclosures and new data at #ash22, demonstrating commitment to raising standards in treatment through broad #multiplemyeloma portfolio $bmy 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.